ID: ALA182612

Max Phase: Preclinical

Molecular Formula: C17H18N6O

Molecular Weight: 322.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(C#CC2(N)CCCCC2)cn2nc(-c3ccco3)nc12

Standard InChI:  InChI=1S/C17H18N6O/c18-14-16-21-15(13-5-4-10-24-13)22-23(16)11-12(20-14)6-9-17(19)7-2-1-3-8-17/h4-5,10-11H,1-3,7-8,19H2,(H2,18,20)

Standard InChI Key:  IJNKMZAOCAUMML-UHFFFAOYSA-N

Associated Targets(non-human)

Adenosine A2a receptor 3360 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A1 receptor 6163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine receptors; A1 & A2a 368 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 322.37Molecular Weight (Monoisotopic): 322.1542AlogP: 1.98#Rotatable Bonds: 1
Polar Surface Area: 108.26Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.99CX LogP: 2.72CX LogD: 1.13
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.66Np Likeness Score: -0.91

References

1. Yao G, Haque S, Sha L, Kumaravel G, Wang J, Engber TM, Whalley ET, Conlon PR, Chang H, Kiesman WF, Petter RC..  (2005)  Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.,  15  (3): [PMID:15664803] [10.1016/j.bmcl.2004.11.062]

Source